Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Specialties, Surgical | 7 | 2024 | 70 | 2.160 |
Why?
|
| Median Arcuate Ligament Syndrome | 6 | 2023 | 23 | 2.070 |
Why?
|
| Child | 45 | 2025 | 7334 | 1.450 |
Why?
|
| Abdominal Pain | 5 | 2023 | 144 | 1.220 |
Why?
|
| Appendicitis | 5 | 2022 | 73 | 1.150 |
Why?
|
| Celiac Artery | 3 | 2023 | 25 | 1.150 |
Why?
|
| Pediatrics | 4 | 2019 | 368 | 1.030 |
Why?
|
| Tracheoesophageal Fistula | 6 | 2022 | 14 | 0.990 |
Why?
|
| Esophageal Atresia | 6 | 2022 | 16 | 0.990 |
Why?
|
| Constriction, Pathologic | 4 | 2022 | 219 | 0.990 |
Why?
|
| Ovarian Neoplasms | 8 | 2023 | 787 | 0.940 |
Why?
|
| Intestinal Obstruction | 3 | 2021 | 91 | 0.900 |
Why?
|
| Pandemics | 4 | 2022 | 812 | 0.870 |
Why?
|
| Gastroschisis | 4 | 2022 | 13 | 0.720 |
Why?
|
| Guilt | 1 | 2020 | 11 | 0.690 |
Why?
|
| Social Responsibility | 1 | 2020 | 57 | 0.670 |
Why?
|
| Laparoscopy | 6 | 2022 | 785 | 0.660 |
Why?
|
| Surgeons | 2 | 2024 | 265 | 0.660 |
Why?
|
| Surgery Department, Hospital | 1 | 2020 | 44 | 0.650 |
Why?
|
| Infant | 20 | 2025 | 3218 | 0.640 |
Why?
|
| Tissue Adhesions | 2 | 2021 | 52 | 0.640 |
Why?
|
| Triage | 1 | 2020 | 125 | 0.640 |
Why?
|
| Appendectomy | 4 | 2021 | 44 | 0.630 |
Why?
|
| Operating Rooms | 1 | 2020 | 134 | 0.620 |
Why?
|
| Diatrizoate Meglumine | 1 | 2018 | 18 | 0.610 |
Why?
|
| Infection Control | 1 | 2020 | 128 | 0.610 |
Why?
|
| Retrospective Studies | 35 | 2025 | 9703 | 0.610 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 159 | 0.600 |
Why?
|
| Humans | 65 | 2025 | 92337 | 0.600 |
Why?
|
| Chronic Pain | 3 | 2018 | 171 | 0.580 |
Why?
|
| Fellowships and Scholarships | 4 | 2022 | 130 | 0.560 |
Why?
|
| Decompression, Surgical | 2 | 2018 | 135 | 0.530 |
Why?
|
| Patient Selection | 1 | 2020 | 689 | 0.510 |
Why?
|
| Adolescent | 21 | 2025 | 9504 | 0.500 |
Why?
|
| Anorectal Malformations | 3 | 2020 | 5 | 0.480 |
Why?
|
| Internship and Residency | 2 | 2021 | 1081 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 328 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 313 | 0.470 |
Why?
|
| Ovariectomy | 4 | 2023 | 86 | 0.460 |
Why?
|
| Contrast Media | 2 | 2021 | 1076 | 0.460 |
Why?
|
| Decision Making | 1 | 2020 | 680 | 0.450 |
Why?
|
| Child, Preschool | 12 | 2025 | 3818 | 0.450 |
Why?
|
| Surgical Procedures, Operative | 1 | 2016 | 210 | 0.430 |
Why?
|
| Ligaments | 1 | 2013 | 34 | 0.430 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2013 | 111 | 0.410 |
Why?
|
| Teratoma | 3 | 2022 | 56 | 0.400 |
Why?
|
| Fecal Incontinence | 3 | 2020 | 59 | 0.390 |
Why?
|
| Dermoid Cyst | 2 | 2022 | 16 | 0.390 |
Why?
|
| Infant, Newborn | 14 | 2025 | 2517 | 0.370 |
Why?
|
| Wounds and Injuries | 2 | 2025 | 267 | 0.370 |
Why?
|
| Treatment Outcome | 20 | 2025 | 8740 | 0.340 |
Why?
|
| Female | 34 | 2025 | 47893 | 0.340 |
Why?
|
| Quality of Life | 7 | 2022 | 1744 | 0.340 |
Why?
|
| Prospective Studies | 13 | 2025 | 4468 | 0.320 |
Why?
|
| Cell Polarity | 2 | 2006 | 117 | 0.300 |
Why?
|
| Length of Stay | 6 | 2024 | 798 | 0.300 |
Why?
|
| Postoperative Complications | 9 | 2024 | 2458 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 810 | 0.270 |
Why?
|
| Male | 25 | 2025 | 43925 | 0.270 |
Why?
|
| Unnecessary Procedures | 2 | 2023 | 53 | 0.250 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 167 | 0.240 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2025 | 5 | 0.240 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2025 | 43 | 0.240 |
Why?
|
| Biliary Atresia | 1 | 2025 | 24 | 0.240 |
Why?
|
| Funnel Chest | 1 | 2024 | 9 | 0.240 |
Why?
|
| Epithelial Cells | 2 | 2006 | 702 | 0.230 |
Why?
|
| Pulmonary Blastoma | 2 | 2022 | 5 | 0.230 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 2394 | 0.230 |
Why?
|
| Anesthesia, Conduction | 1 | 2024 | 22 | 0.230 |
Why?
|
| Hospitals, High-Volume | 1 | 2024 | 39 | 0.230 |
Why?
|
| Young Adult | 10 | 2023 | 6624 | 0.230 |
Why?
|
| Esophageal Stenosis | 2 | 2022 | 26 | 0.220 |
Why?
|
| Burns | 1 | 2006 | 145 | 0.220 |
Why?
|
| Mental Disorders | 2 | 2018 | 424 | 0.220 |
Why?
|
| Drainage | 1 | 2025 | 169 | 0.220 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 272 | 0.210 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 130 | 0.210 |
Why?
|
| Testicular Hydrocele | 1 | 2022 | 4 | 0.200 |
Why?
|
| Organ Sparing Treatments | 2 | 2021 | 47 | 0.200 |
Why?
|
| Respiratory System Abnormalities | 2 | 2019 | 5 | 0.200 |
Why?
|
| Venous Thrombosis | 1 | 2025 | 253 | 0.200 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2022 | 48 | 0.190 |
Why?
|
| Thoracotomy | 2 | 2022 | 65 | 0.190 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 275 | 0.190 |
Why?
|
| Hernia, Umbilical | 1 | 2022 | 17 | 0.190 |
Why?
|
| Cicatrix | 1 | 2022 | 71 | 0.190 |
Why?
|
| Venous Thromboembolism | 1 | 2024 | 164 | 0.190 |
Why?
|
| Hernia, Inguinal | 1 | 2022 | 76 | 0.180 |
Why?
|
| Fibroadenoma | 1 | 2021 | 9 | 0.180 |
Why?
|
| Phyllodes Tumor | 1 | 2021 | 7 | 0.180 |
Why?
|
| Ovarian Cysts | 1 | 2021 | 17 | 0.180 |
Why?
|
| Insurance Coverage | 1 | 2022 | 134 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2024 | 443 | 0.180 |
Why?
|
| Cystadenoma | 1 | 2021 | 19 | 0.180 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 105 | 0.180 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 3775 | 0.180 |
Why?
|
| Hospitalization | 3 | 2023 | 927 | 0.180 |
Why?
|
| Watchful Waiting | 1 | 2021 | 69 | 0.170 |
Why?
|
| Anthropometry | 1 | 2020 | 75 | 0.170 |
Why?
|
| Mastectomy, Segmental | 1 | 2021 | 101 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 32 | 0.170 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2020 | 6 | 0.170 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 15 | 0.170 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 36 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 172 | 0.170 |
Why?
|
| Ileostomy | 1 | 2000 | 29 | 0.170 |
Why?
|
| Thoracentesis | 1 | 2019 | 3 | 0.170 |
Why?
|
| Sacrum | 1 | 2020 | 57 | 0.170 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2019 | 8 | 0.170 |
Why?
|
| Abdominal Wall | 1 | 2020 | 31 | 0.160 |
Why?
|
| Chest Tubes | 1 | 2019 | 23 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2022 | 282 | 0.160 |
Why?
|
| Sutures | 1 | 2020 | 60 | 0.160 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2019 | 71 | 0.160 |
Why?
|
| alpha-Fetoproteins | 1 | 2019 | 45 | 0.160 |
Why?
|
| Abnormalities, Multiple | 2 | 2018 | 237 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 2729 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2023 | 2369 | 0.160 |
Why?
|
| Pneumothorax | 1 | 2019 | 52 | 0.160 |
Why?
|
| Registries | 2 | 2019 | 902 | 0.150 |
Why?
|
| Lung | 3 | 2022 | 1337 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2000 | 118 | 0.150 |
Why?
|
| Vascular Ring | 1 | 2018 | 1 | 0.150 |
Why?
|
| Cross Infection | 1 | 2020 | 153 | 0.150 |
Why?
|
| Pneumonectomy | 1 | 2021 | 215 | 0.150 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 39 | 0.150 |
Why?
|
| Biomarkers, Tumor | 3 | 2023 | 1576 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2022 | 2680 | 0.140 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 149 | 0.140 |
Why?
|
| Preoperative Care | 2 | 2023 | 406 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 269 | 0.130 |
Why?
|
| Thoracoscopy | 3 | 2022 | 24 | 0.130 |
Why?
|
| Predictive Value of Tests | 4 | 2023 | 1763 | 0.130 |
Why?
|
| Cohort Studies | 6 | 2022 | 2978 | 0.130 |
Why?
|
| Intestine, Small | 1 | 2018 | 301 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2018 | 248 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 259 | 0.130 |
Why?
|
| Program Development | 1 | 2016 | 130 | 0.130 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 134 | 0.120 |
Why?
|
| Integrins | 2 | 2006 | 79 | 0.120 |
Why?
|
| Hospitals, Pediatric | 3 | 2021 | 127 | 0.120 |
Why?
|
| Incidence | 4 | 2024 | 1661 | 0.120 |
Why?
|
| Laminin | 2 | 2006 | 93 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2016 | 174 | 0.110 |
Why?
|
| United States | 6 | 2025 | 7348 | 0.110 |
Why?
|
| Midwestern United States | 3 | 2019 | 85 | 0.110 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 400 | 0.110 |
Why?
|
| Enteric Nervous System | 1 | 2013 | 7 | 0.110 |
Why?
|
| Disease Management | 1 | 2016 | 340 | 0.110 |
Why?
|
| Diaphragm | 1 | 2013 | 52 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2013 | 173 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2013 | 41 | 0.100 |
Why?
|
| Early Diagnosis | 1 | 2013 | 129 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 121 | 0.100 |
Why?
|
| Reoperation | 2 | 2013 | 654 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 619 | 0.100 |
Why?
|
| Canada | 2 | 2024 | 205 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2016 | 404 | 0.100 |
Why?
|
| Risk Factors | 4 | 2025 | 5704 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2013 | 963 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 2794 | 0.080 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 505 | 0.080 |
Why?
|
| Propensity Score | 2 | 2021 | 165 | 0.080 |
Why?
|
| Appendix | 2 | 2020 | 31 | 0.080 |
Why?
|
| Prenatal Diagnosis | 2 | 2021 | 110 | 0.080 |
Why?
|
| Dogs | 2 | 2006 | 705 | 0.070 |
Why?
|
| Cloaca | 1 | 2008 | 4 | 0.070 |
Why?
|
| Anus, Imperforate | 1 | 2008 | 12 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2021 | 708 | 0.070 |
Why?
|
| Cysts | 1 | 2009 | 103 | 0.070 |
Why?
|
| Surgical Stomas | 1 | 2008 | 22 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 3053 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 800 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2009 | 246 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1592 | 0.070 |
Why?
|
| Burn Units | 1 | 2006 | 21 | 0.070 |
Why?
|
| Trauma Severity Indices | 1 | 2006 | 46 | 0.060 |
Why?
|
| Trachea | 2 | 2017 | 291 | 0.060 |
Why?
|
| Anastomotic Leak | 2 | 2017 | 108 | 0.060 |
Why?
|
| Age Factors | 2 | 2021 | 1905 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2006 | 283 | 0.060 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2004 | 49 | 0.060 |
Why?
|
| Bilirubin | 1 | 2025 | 134 | 0.060 |
Why?
|
| Colon | 1 | 2008 | 527 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 561 | 0.060 |
Why?
|
| Cryosurgery | 1 | 2024 | 60 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 3110 | 0.060 |
Why?
|
| Algorithms | 2 | 2023 | 1956 | 0.060 |
Why?
|
| Trauma Centers | 1 | 2025 | 160 | 0.060 |
Why?
|
| Time Factors | 2 | 2018 | 5430 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1919 | 0.050 |
Why?
|
| North America | 1 | 2024 | 188 | 0.050 |
Why?
|
| Oregon | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cell Movement | 1 | 2006 | 797 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2074 | 0.050 |
Why?
|
| Frozen Sections | 1 | 2022 | 49 | 0.050 |
Why?
|
| Laparotomy | 1 | 2022 | 68 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3017 | 0.050 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2021 | 12 | 0.050 |
Why?
|
| Herniorrhaphy | 1 | 2022 | 93 | 0.050 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2021 | 15 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2021 | 16 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2902 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2021 | 305 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 65 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 280 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 57 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 150 | 0.040 |
Why?
|
| Selection Bias | 1 | 2020 | 36 | 0.040 |
Why?
|
| Ultrasonography, Mammary | 1 | 2021 | 81 | 0.040 |
Why?
|
| Meconium | 1 | 2000 | 15 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1720 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 472 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 4067 | 0.040 |
Why?
|
| Inhibins | 1 | 2019 | 38 | 0.040 |
Why?
|
| Water | 1 | 2021 | 292 | 0.040 |
Why?
|
| Adult | 4 | 2022 | 27532 | 0.040 |
Why?
|
| Ovary | 1 | 2021 | 263 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 406 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 33 | 0.040 |
Why?
|
| Breast | 1 | 2021 | 289 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 2009 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 289 | 0.040 |
Why?
|
| Observer Variation | 1 | 2020 | 612 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 800 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 291 | 0.040 |
Why?
|
| Dyspnea | 1 | 2019 | 80 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2022 | 411 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 856 | 0.040 |
Why?
|
| Radiography | 1 | 2020 | 795 | 0.040 |
Why?
|
| Medicine | 1 | 2019 | 95 | 0.040 |
Why?
|
| Motivation | 1 | 2021 | 310 | 0.040 |
Why?
|
| Patient Preference | 1 | 2019 | 120 | 0.040 |
Why?
|
| Esophagus | 1 | 2018 | 107 | 0.040 |
Why?
|
| Curriculum | 1 | 2022 | 581 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1902 | 0.040 |
Why?
|
| Histamine H2 Antagonists | 1 | 2017 | 14 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 155 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 444 | 0.030 |
Why?
|
| Vocal Cord Paralysis | 1 | 2017 | 26 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 167 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 169 | 0.030 |
Why?
|
| Esophagoplasty | 1 | 2016 | 10 | 0.030 |
Why?
|
| Mental Health | 1 | 2018 | 184 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 900 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 1071 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2018 | 360 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 307 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 82 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1180 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 498 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 180 | 0.030 |
Why?
|
| Research Design | 1 | 2019 | 600 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 189 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1239 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2016 | 167 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 987 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 1150 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 1079 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3872 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 304 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3509 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 485 | 0.020 |
Why?
|
| Animals | 2 | 2006 | 28003 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 4204 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2013 | 1733 | 0.020 |
Why?
|
| Cilia | 1 | 2009 | 29 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 1927 | 0.020 |
Why?
|
| Bladder Exstrophy | 1 | 2008 | 10 | 0.020 |
Why?
|
| Colostomy | 1 | 2008 | 14 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2004 | 74 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 200 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 431 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 698 | 0.010 |
Why?
|
| Middle Aged | 2 | 2013 | 27030 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 2505 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19943 | 0.010 |
Why?
|